E Wildhirt
About
In The Last Decade
E Wildhirt
64 papers receiving 371 citations
Peers
Comparison fields: 5 of 76
- Epidemiology 138
- Molecular Biology 96
- Hepatology 94
- Clinical Biochemistry 86
- Pharmacology 76
Countries citing papers authored by E Wildhirt
This map shows the geographic impact of E Wildhirt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Wildhirt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Wildhirt more than expected).
Fields of papers citing papers by E Wildhirt
This network shows the impact of papers produced by E Wildhirt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Wildhirt. The network helps show where E Wildhirt may publish in the future.
Co-authorship network of co-authors of E Wildhirt
This figure shows the co-authorship network connecting the top 25 collaborators of E Wildhirt. A scholar is included among the top collaborators of E Wildhirt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Wildhirt. E Wildhirt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | [A peculiar type of chronic persisting hepatitis (author's transl)]. | 1 |
| 2 | 1 | |
| 3 | The treatment of chronic liver disease with D-penicillamine. | 2 |
| 4 | [Serum protein changes in the diagnosis of liver diseases]. | 1 |
| 5 | [Limitation of the indication for laparoscopy and percutaneous liver biopsy in liver diseases]. | 2 |
| 6 | The treatment of chronic hepatitis. | 1 |
| 7 | 0 | |
| 8 | [The terminal stage of liver diseases and hepatic coma]. | 3 |
| 9 | Zur Beteiligung der Leber bei der infektiösen Mononucleose: Ferment-Aktivitäts-Bestimmungen in der menschlichen Leber. VIII | 1 |
| 10 | Fortschritte der Gastroenterologie | 20 |
| 11 | 9 | |
| 12 | 1 | |
| 13 | 62 | |
| 14 | 10 | |
| 15 | 15 | |
| 16 | [Treatment of liver cirrhosis with prednisone & prednisolone]. | 2 |
| 17 | 5 | |
| 18 | 5 | |
| 19 | [Chemotherapy of diffuse diseases of liver parenchyma]. | 1 |
| 20 | [Treatment of chronic hepatitis and biliary cirrhosis with liver extracts]. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.